Intrapleural chemotherapy with and without surgery in malignant pleural mesothelioma (MPM)

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Conclusion and Future Directions: Intrapleural delivery is an effective way of delivering chemotherapy in patients with MPM. Intrapleural chemotherapy can be particularly effective early, when the disease is limited to the pleural surface. However, the current data with the adjuvant intrapleural chemotherapy is inconclusive and should not be routinely used except in the setting of clinical trials. Our results with intrapleural L-NDDP are very encouraging and warrant further studies either as a neoadjuvant or an adjuvant to debulking surgery or in combination with intravenous chemotherapy.

Original languageEnglish (US)
Title of host publicationMalignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies
PublisherSpringer New York
Pages631-637
Number of pages7
ISBN (Print)0387229493, 9780387229492
DOIs
StatePublished - 2005

Fingerprint

Drug Therapy
Adjuvant Chemotherapy
Clinical Trials
Malignant Mesothelioma
bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)
Direction compound

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Piperdi, B., Shin, D. M., & Perez-Soler, R. (2005). Intrapleural chemotherapy with and without surgery in malignant pleural mesothelioma (MPM). In Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies (pp. 631-637). Springer New York. https://doi.org/10.1007/0-387-28274-2_42

Intrapleural chemotherapy with and without surgery in malignant pleural mesothelioma (MPM). / Piperdi, Bilal; Shin, Dong M.; Perez-Soler, Roman.

Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies. Springer New York, 2005. p. 631-637.

Research output: Chapter in Book/Report/Conference proceedingChapter

Piperdi, B, Shin, DM & Perez-Soler, R 2005, Intrapleural chemotherapy with and without surgery in malignant pleural mesothelioma (MPM). in Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies. Springer New York, pp. 631-637. https://doi.org/10.1007/0-387-28274-2_42
Piperdi B, Shin DM, Perez-Soler R. Intrapleural chemotherapy with and without surgery in malignant pleural mesothelioma (MPM). In Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies. Springer New York. 2005. p. 631-637 https://doi.org/10.1007/0-387-28274-2_42
Piperdi, Bilal ; Shin, Dong M. ; Perez-Soler, Roman. / Intrapleural chemotherapy with and without surgery in malignant pleural mesothelioma (MPM). Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies. Springer New York, 2005. pp. 631-637
@inbook{1a4bedfdba0643f5875572148fbf1901,
title = "Intrapleural chemotherapy with and without surgery in malignant pleural mesothelioma (MPM)",
abstract = "Conclusion and Future Directions: Intrapleural delivery is an effective way of delivering chemotherapy in patients with MPM. Intrapleural chemotherapy can be particularly effective early, when the disease is limited to the pleural surface. However, the current data with the adjuvant intrapleural chemotherapy is inconclusive and should not be routinely used except in the setting of clinical trials. Our results with intrapleural L-NDDP are very encouraging and warrant further studies either as a neoadjuvant or an adjuvant to debulking surgery or in combination with intravenous chemotherapy.",
author = "Bilal Piperdi and Shin, {Dong M.} and Roman Perez-Soler",
year = "2005",
doi = "10.1007/0-387-28274-2_42",
language = "English (US)",
isbn = "0387229493",
pages = "631--637",
booktitle = "Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies",
publisher = "Springer New York",

}

TY - CHAP

T1 - Intrapleural chemotherapy with and without surgery in malignant pleural mesothelioma (MPM)

AU - Piperdi, Bilal

AU - Shin, Dong M.

AU - Perez-Soler, Roman

PY - 2005

Y1 - 2005

N2 - Conclusion and Future Directions: Intrapleural delivery is an effective way of delivering chemotherapy in patients with MPM. Intrapleural chemotherapy can be particularly effective early, when the disease is limited to the pleural surface. However, the current data with the adjuvant intrapleural chemotherapy is inconclusive and should not be routinely used except in the setting of clinical trials. Our results with intrapleural L-NDDP are very encouraging and warrant further studies either as a neoadjuvant or an adjuvant to debulking surgery or in combination with intravenous chemotherapy.

AB - Conclusion and Future Directions: Intrapleural delivery is an effective way of delivering chemotherapy in patients with MPM. Intrapleural chemotherapy can be particularly effective early, when the disease is limited to the pleural surface. However, the current data with the adjuvant intrapleural chemotherapy is inconclusive and should not be routinely used except in the setting of clinical trials. Our results with intrapleural L-NDDP are very encouraging and warrant further studies either as a neoadjuvant or an adjuvant to debulking surgery or in combination with intravenous chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=28444448701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28444448701&partnerID=8YFLogxK

U2 - 10.1007/0-387-28274-2_42

DO - 10.1007/0-387-28274-2_42

M3 - Chapter

AN - SCOPUS:28444448701

SN - 0387229493

SN - 9780387229492

SP - 631

EP - 637

BT - Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies

PB - Springer New York

ER -